vs
Side-by-side financial comparison of ASCENT INDUSTRIES CO. (ACNT) and Autolus Therapeutics plc (AUTL). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $11.9M, roughly 1.8× ASCENT INDUSTRIES CO.). ASCENT INDUSTRIES CO. runs the higher net margin — -8.8% vs -373.3%, a 364.5% gap on every dollar of revenue. ASCENT INDUSTRIES CO. produced more free cash flow last quarter ($-196.0K vs $-72.3M).
ASCENT INDUSTRIES CO.ACNTEarnings & Financial Report
Ascent Capital Group, Inc. was a publicly traded holding company whose primary subsidiary was Monitronics. Ascent Media was a wholly owned subsidiary of the Discovery Holding Company (DHC). DHC spun off Ascent Media as an independent, public company on September 17, 2008.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
ACNT vs AUTL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.9M | $21.2M |
| Net Profit | $-1.0M | $-79.1M |
| Gross Margin | 14.6% | — |
| Operating Margin | -21.0% | -337.9% |
| Net Margin | -8.8% | -373.3% |
| Revenue YoY | 13.3% | — |
| Net Profit YoY | -1.2% | 3.6% |
| EPS (diluted) | $-0.11 | $-0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.9M | — | ||
| Q3 25 | $19.7M | $21.2M | ||
| Q2 25 | $18.7M | $20.9M | ||
| Q1 25 | $24.7M | $9.0M | ||
| Q4 24 | $10.5M | — | ||
| Q3 24 | $20.9M | $0 | ||
| Q2 24 | $21.5M | $0 | ||
| Q1 24 | $28.0M | $10.1M |
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-2.1M | $-79.1M | ||
| Q2 25 | $6.3M | $-47.9M | ||
| Q1 25 | $-2.3M | $-70.2M | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $-6.2M | $-82.1M | ||
| Q2 24 | $-926.0K | $-58.3M | ||
| Q1 24 | $-5.5M | $-52.7M |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 19.3% | — | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 13.1% | — | ||
| Q1 24 | 8.3% | — |
| Q4 25 | -21.0% | — | ||
| Q3 25 | -4.1% | -337.9% | ||
| Q2 25 | -14.4% | -292.6% | ||
| Q1 25 | -4.2% | -726.3% | ||
| Q4 24 | -25.4% | — | ||
| Q3 24 | -9.4% | — | ||
| Q2 24 | -8.6% | — | ||
| Q1 24 | -15.5% | -384.1% |
| Q4 25 | -8.8% | — | ||
| Q3 25 | -10.6% | -373.3% | ||
| Q2 25 | 33.7% | -229.0% | ||
| Q1 25 | -9.3% | -781.1% | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -29.5% | — | ||
| Q2 24 | -4.3% | — | ||
| Q1 24 | -19.7% | -522.1% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.22 | $-0.30 | ||
| Q2 25 | $0.65 | $-0.18 | ||
| Q1 25 | $-0.23 | $-0.26 | ||
| Q4 24 | $-0.11 | — | ||
| Q3 24 | $-0.61 | $-0.31 | ||
| Q2 24 | $-0.09 | $-0.22 | ||
| Q1 24 | $-0.54 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.6M | $86.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $87.0M | $265.5M |
| Total Assets | $111.9M | $661.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | — | ||
| Q3 25 | $58.0M | $86.1M | ||
| Q2 25 | $60.5M | $123.8M | ||
| Q1 25 | $14.3M | $95.8M | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $8.5M | $657.1M | ||
| Q2 24 | $3.6M | $705.9M | ||
| Q1 24 | $1.3M | $758.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $87.0M | — | ||
| Q3 25 | $87.1M | $265.5M | ||
| Q2 25 | $89.7M | $346.5M | ||
| Q1 25 | $91.2M | $371.1M | ||
| Q4 24 | $93.5M | — | ||
| Q3 24 | $94.7M | $477.0M | ||
| Q2 24 | $101.0M | $527.8M | ||
| Q1 24 | $102.0M | $582.0M |
| Q4 25 | $111.9M | — | ||
| Q3 25 | $119.9M | $661.9M | ||
| Q2 25 | $122.6M | $721.0M | ||
| Q1 25 | $152.5M | $746.3M | ||
| Q4 24 | $147.3M | — | ||
| Q3 24 | $148.6M | $827.5M | ||
| Q2 24 | $158.2M | $853.6M | ||
| Q1 24 | $161.0M | $901.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $266.0K | $-67.9M |
| Free Cash FlowOCF − Capex | $-196.0K | $-72.3M |
| FCF MarginFCF / Revenue | -1.7% | -341.2% |
| Capex IntensityCapex / Revenue | 3.9% | 20.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.1M | $-322.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $266.0K | — | ||
| Q3 25 | $1.3M | $-67.9M | ||
| Q2 25 | $-1.4M | $-72.8M | ||
| Q1 25 | $-700.0K | $-75.6M | ||
| Q4 24 | $8.8M | — | ||
| Q3 24 | $3.4M | $-76.7M | ||
| Q2 24 | $2.2M | $-51.1M | ||
| Q1 24 | $263.0K | $-40.5M |
| Q4 25 | $-196.0K | — | ||
| Q3 25 | $695.0K | $-72.3M | ||
| Q2 25 | $-1.5M | $-80.1M | ||
| Q1 25 | $-1.0M | $-83.8M | ||
| Q4 24 | $8.4M | — | ||
| Q3 24 | $3.1M | $-86.3M | ||
| Q2 24 | $1.9M | $-51.9M | ||
| Q1 24 | $25.0K | $-41.0M |
| Q4 25 | -1.7% | — | ||
| Q3 25 | 3.5% | -341.2% | ||
| Q2 25 | -8.3% | -382.6% | ||
| Q1 25 | -4.1% | -933.1% | ||
| Q4 24 | 80.6% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 0.1% | -406.8% |
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.1% | 20.8% | ||
| Q2 25 | 0.8% | 34.8% | ||
| Q1 25 | 1.3% | 91.8% | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.9% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACNT
| Other | $6.1M | 52% |
| Transferred At Point In Time | $5.7M | 48% |
AUTL
Segment breakdown not available.
